As a member of Impact Advisors’ Discovery & Development team, Mr. Fortin has over 10 years of experience researching emerging healthcare IT trends and analyzing the impact of regulatory requirements on healthcare strategic planning, operations and
delivery. Mr. Fortin’s areas of expertise include IS strategic planning, payment reform, health information exchange, and business intelligence / data analytics.
Posted April 2019
CMS and ONC Proposed Rules on Interoperability, Patient Access, Information Blocking, and EHR Certification
Dan Golder, DDS, MBA, Principal Advisor, and Jason Fortin, Senior Advisor, Impact Advisors. This session focuses on two proposed rules ...
Read More
Read More
This Just in: MIPS Information Blocking – New Attestation Requirements for 2017!
Dan Golder, DDS, MBA, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor Impact Advisors. This session provides late-breaking ...
Read More
Read More
MIPS & MACRA Proposed Rule: What’s Changed for 2018 and Beyond
Dan Golder, DDS, MBA, Principal Advisor, Henry Stokman, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor, Impact Advisors. This session examines ...
Read More
Read More
Alternative Payment Models: MACRA, Part III
Dan Golder, DDS, MBA, Principal Advisor, Henry Stokman, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor, Impact Advisors ...
Read More
Read More
MIPS Math: An In-depth Look at the MIPS Scoring Methodology, Part II
Dan Golder, MD, Principal Advisor, Henry Stokman, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor, Impact Advisors. This session ...
Read More
Read More
Healthcare Trends 2015: Staying Competitive Amid Rising Pressures
Keith MacDonald, Vice President, and Jason Fortin, Senior Advisor Discovery & Development, Impact Advisors. Keith and Jason discuss the pressures ...
Read More
Read More
Timelines/Nuances of Reporting and Penalties
Laura Kreofsky, PMP, CPHIMS, Principal, and Jason Fortin, Senior Advisor, Impact Advisors. Jason and Laura review key MU Stage 2 ...
Read More
Read More
Meaningful Use: Stage 2 and Beyond
Jason Fortin, Director, and Erica Drazen, Managing Director, Global Institute for Emerging Healthcare Practices, CSC. While nothing is final, we ...
Read More
Read More
Meaningful Use: What Has Changed Since the Final Rule and the Proposed Requirements for Stage 2?
Erica Drazen, Managing Partner, Emerging Practices, and Jason Fortin, Senior Research Analyst, CSC, discuss what has changed since the Final ...
Read More
Read More
Meaningful Use: What has changed since the ‘Final’ Rule?
Erica Drazen Managing Partner, Emerging Practices, and Jason Fortin, Senior Research Analyst, CSC, discuss what has changed since the Final ...
Read More
Read More